On 05/15/2013, The X-Change Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

The X-Change Corporation announced the appointment of drs. Mario Lap as Director of European Operations for the company and several Dutch subsidiaries that are being formed by the company in the Netherlands. Mr. Lap brings to the company a unique combination of expertise in Dutch and greater European medical cannabis law and policy as well as in the areas of health care, IT security, law enforcement, and government relations. Mr. Lap currently serves as Director, Foundation on Drug Policy and Human Rights, and Director, Drugtext Foundation, and as a Director of various private ventures. Mr. Lap also served as Director of Sales of Apcare B.V., Director of Yalado International B.V., Founder and Director, Calyx Internet B.V. and Calyx Internet Corporation, Professor at the Rechercheschool (Dutch National Police Academy), Head of the Legal and Policy Department of the Netherlands Institute on Alcohol and Other Drugs, and Head of Legal and Policy Department, and Pilot Project of European Monitoring Center on Drugs and Drug Addiction.

The X-Change Corporation filed its 10-K on Apr 26, 2013 for the period ending Dec 31, 2012. In this report its auditor, S. W. Hatfield & Associates, gave an unqualified opinion expressing doubt that the company can continue as a going concern.